FBXL7 and central nervous system cancer: We could also show that knock‐down of FBXL7 improved inhibitory effects mediated by TMZ glioma xenograft growth in vivo and on viability of glioma cell in vitro and that FBXL7 expression was inhibited in glioma cells by miR‐152‐5p via direct interaction.